1. 116PLarge scale functional characterization of mutations and their susceptibility to targeted therapy. (7th November 2019) Authors: Barbash, Z; Tarcic, G; Haham, D; Hafzadi, L; Zipor, R; Barth, S; Aizenman, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 7 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 44PCorrelation between an automated functional assay that predicts targeted agent (TA) sensitivity and the tumor response of the sorafenib treatment evaluated within the MOST clinical trial. (16th September 2018) Authors: Tredan, O; Zelichov, O; Barbash, Z; Daitsh, Y; Birnbaum, L; Tarcic, G; You, B; Cassier, P; de la Fouchardiere, C; Ray-Coquard, I L; Brahmi, M; Wang, Q; Attignon, V; Baudet, C; Fournier Garin, G; Agrapart, V; Dargenio, A; Chabaud, S; Perol, D; Blay, J-Y Journal: Annals of oncology Issue: Volume 29:Number 6(2018)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗